Ninety-five cases of intestinal transplantation at the University of Miami.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 11992809)

Published in J Gastrointest Surg on May 06, 2002

Authors

Seigo Nishida1, David Levi, Tomoaki Kato, Jose R Nery, Naveen Mittal, Nicholas Hadjis, Juan Madariaga, Andreas G Tzakis

Author Affiliations

1: Division of Transplantation, Department of Surgery, University of Miami, Miami, FL 33136, USA. snishida@med.miami.edu

Articles by these authors

Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology (2014) 3.29

Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity (2012) 3.21

When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg (2014) 2.23

Mucosal vascular alterations in isolated small-bowel allografts: relationship to humoral sensitization. Am J Transplant (2003) 1.64

Intestinal transplantation for the treatment of neoplastic disease. J Surg Oncol (2005) 1.62

Transplantation of the abdominal wall. Lancet (2003) 1.51

Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation. Transplantation (2002) 1.42

Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transpl (2004) 1.42

Infrahepatic vena cavocavostomy, a modification of the piggyback technique for liver transplantation. Am Surg (2009) 1.40

Analysis of vascular access in intestinal transplant recipients using the Miami classification from the VIIIth International Small Bowel Transplant Symposium. Transplantation (2005) 1.40

Living-related intestinal transplantation for a patient with hypoganglionosis. Pediatr Transplant (2006) 1.39

Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39

100 multivisceral transplants at a single center. Ann Surg (2005) 1.34

A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications. Transplantation (2004) 1.30

Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation (2003) 1.28

Changing concepts in the management of liver hydatid disease. J Gastrointest Surg (2005) 1.28

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. Transplantation (2005) 1.25

Intestinal and multivisceral transplantation. World J Surg (2001) 1.25

Intestinal and multivisceral transplantation in children. Ann Surg (2006) 1.22

Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation (2006) 1.22

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation (2002) 1.11

Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation (2011) 1.06

Intrahepatic biliary strictures after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.05

Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation (2012) 1.03

Amyloidosis of the upper aerodigestive tract. Laryngoscope (2003) 1.03

Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome. Surg Endosc (2009) 1.02

Donor intracaval thrombus formation and pulmonary embolism after simultaneous piggyback liver transplantation and aortic valve replacement. Clin Transplant (2003) 1.02

Intestinal transplantation in children: a summary of clinical outcomes and prognostic factors in 108 patients from a single center. J Gastrointest Surg (2005) 1.01

The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant (2005) 1.01

Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. J Pediatr Gastroenterol Nutr (2006) 1.01

Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation (2004) 0.99

The use of Campath-1H as induction therapy in renal transplantation: preliminary results. Transplantation (2004) 0.99

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl (2003) 0.97

Effect of protocol Doppler ultrasonography and urgent revascularization on early hepatic artery thrombosis after pediatric liver transplantation. Arch Surg (2002) 0.95

Propylthiouracil-induced acute liver failure: role of liver transplantation. Int J Endocrinol (2010) 0.95

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation. Transpl Immunol (2003) 0.95

Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation (2011) 0.95

Piggyback technique in adult orthotopic liver transplantation: an analysis of 1067 liver transplants at a single center. HPB (Oxford) (2006) 0.95

Arabidopsis ENHANCED DISEASE RESISTANCE 1 is required for pathogen-induced expression of plant defensins in nonhost resistance, and acts through interference of MYC2-mediated repressor function. Plant J (2011) 0.95

The effect of immunosuppression on peritoneal adhesions formation after small bowel transplantation in rats. J Surg Res (2007) 0.95

Combined liver and lung metastasectomy through an exclusive transthoracic approach. J Surg Oncol (2007) 0.94

Loss of heterochromatin protein 1 gamma reduces the number of primordial germ cells via impaired cell cycle progression in mice. Biol Reprod (2011) 0.94

Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. Transplantation (2003) 0.93

Current role of bloodless liver resection. World J Gastroenterol (2007) 0.93

Current status of transplantation of the small intestine. Transplantation (2007) 0.93

Living-related liver transplantation with renoportal anastomosis for a patient with large spontaneous splenorenal collateral. Transplantation (2003) 0.92

Use of older controlled non-heart-beating donors for liver transplantation. Transplantation (2003) 0.92

Hepatic resection for hepatocellular carcinoma exceeding Milan criteria. Surg Oncol (2009) 0.92

Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era. J Am Coll Surg (2010) 0.92

Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg (2003) 0.92

Combined liver and inferior vena cava resection for hepatic malignancy. J Surg Oncol (2007) 0.91

Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol (2003) 0.91

Small-bowel allograft biopsies in the management of small-intestinal and multivisceral transplant recipients: histopathologic review and clinical correlations. Arch Pathol Lab Med (2012) 0.91

Burkitt s lymphoma variant of post-transplant lymphoproliferative disease (PTLD). Pathol Oncol Res (2002) 0.91

Living-donor liver transplantation with renoportal anastomosis for patients with large spontaneous splenorenal shunts. Transplantation (2005) 0.90

A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection. Liver Transpl (2003) 0.90

Gastroduodenal artery steal syndrome during liver transplantation: intraoperative diagnosis with Doppler ultrasound and management. Transpl Int (2005) 0.90

Liver transplantation for severe hepatic trauma: experience from a single center. World J Gastroenterol (2009) 0.90

Characterization of an elicitor-induced rice WRKY gene, OsWRKY71. Biosci Biotechnol Biochem (2008) 0.90

Intestinal and multivisceral transplantation in children with severe gastrointestinal dysmotility. J Pediatr Surg (2005) 0.90

Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation (2003) 0.89

Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival. Transplantation (2012) 0.89

Long-term deleterious effects of aortohepatic conduits in primary liver transplantation: proceed with caution. Liver Transpl (2013) 0.88

Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade. Liver Transpl (2004) 0.88